Juvenile parkinsonism.
D000328:Adult; D000367:Age Factors; D000368:Aged; D003937:Diagnosis, Differential; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D010300:Parkinson Disease / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000235:genetics*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010375:Pedigree; D013035:Spasm / Q000209:etiology; D014149:Tranquilizing Agents / Q000009:adverse effects; D014202:Tremor / Q000175:diagnosis; D014443:Tyrosine; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D014149:Tranquilizing Agents; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D006899:Mixed Function Oxygenases; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine